当前位置：首页 > 文献互助 > 互助详情

2024年度中国新药盘点复制

用户SpcnUTvevLaY 9个月前 138 10 已关闭

DOI:复制

文献链接:复制

其他信息:

上一篇：2023年度中国新药盘点

下一篇：Stability assessment of Polatuzumab vedotin and Brentuximab vedotin using different analytical techniques

互助时间线

2025-08-19 18:52:28 [关闭求助]

楼主用户SpcnUTvevLaY关闭了求助

2025-08-19 18:46:26 [发起求助]

最新发布的求助

Pimavanserin for negative symptoms of schizophrenia: results from the ADVANCE phase 2 randomised, placebo-controlled trial in North America and Europe 9分钟前
Assessment of cartilage regeneration in initial and second-look arthroscopy following low tibial osteotomy for varus osteoarthritis of the ankle 1小时前
Lead Optimization of TgCDPK1 Inhibitors for the Treatment of Toxoplasmosis 1小时前
Linker-Driven Sampling of PROTAC-Induced Ternary Complexes 1小时前
Viscoelastic Supramolecular Hyaluronan-Peptide Cross-Linked Hydrogels 1小时前
Factor B inhibitor iptacopan for the treatment of paroxysmal nocturnal hemoglobinuria 2小时前
Difluoroenol phosphinates as difluoroenolate surrogates: synthesis and applications in defluorination and deoxygenative coupling 2小时前
基于全基因组的金针菇光受体基因鉴定及表达分析 3小时前
15-strain live biotherapeutic product or same donor fecal microbiota transplant for recurrent Clostridioides difficile infection: a randomized phase 1b trial 3小时前
Nonprecious Core–Shell Catalysts for Durable High-Performance Water Electrolysis 3小时前
2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association 3小时前
Pharmacological evaluation of Orai-1 inhibitor in 3-nitropropionic acid-induced Huntington disease 4小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com